Elliott Sun
Analyste en capital-investissement chez Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
Postes actifs de Elliott Sun
Sociétés | Poste | Début | Fin |
---|---|---|---|
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. Investment ManagersFinance Zhouling Private Equity Fund Management (Shanghai) Co Ltd (LYFE Capital) is a private equity/venture capital firm founded in 2015 by James Zhao. The firm is headquartered in Shanghai, China. | Analyste en capital-investissement | - | - |
Historique de carrière de Elliott Sun
Anciens postes connus de Elliott Sun
Sociétés | Poste | Début | Fin |
---|---|---|---|
Biomap (Beijing) Intelligent Technology Co., Ltd.
Biomap (Beijing) Intelligent Technology Co., Ltd. Information Technology ServicesTechnology Services Biomap (Beijing) Intelligent Technology Co., Ltd. is a Chinese biotech company founded in 2020 by Robin Li and Wei Liu. The company is based in Beijing, China and is the first biocomputing-driven biotech company in China. Biomaps' technology, Xtrimo, is a protein-centric large language model platform that allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. The company's mission is to leverage AI and data to radically improve patients' lives by accelerating the R&D process of early screening/diagnosis, drug discovery, and other precision medicine products. Biomaps' focus is on building their internal AI engine and data collection capabilities to curate their proprietary insights for difficult diseases. The company is a startup biotech company aiming to accelerate novel drug discovery for unmet medical needs. Wei Liu has been the CEO since 2020. | Analyste en capital-investissement | - | - |
Baidu Ventures
Baidu Ventures Investment ManagersFinance Baidu Ventures is a venture capital firm headquartered in Beijing, China. The firm was established in 2016. | Analyste en capital-investissement | - | - |
Formation de Elliott Sun
University of Oxford | Doctorate Degree |
University College London | Graduate Degree |
Xiamen University | Undergraduate Degree |
Statistiques
Internationale
Chine | 5 |
Royaume-Uni | 3 |
Opérationnelle
Private Equity Analyst | 3 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 4 |
Finance | 3 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. Investment ManagersFinance Zhouling Private Equity Fund Management (Shanghai) Co Ltd (LYFE Capital) is a private equity/venture capital firm founded in 2015 by James Zhao. The firm is headquartered in Shanghai, China. | Finance |
Baidu Ventures
Baidu Ventures Investment ManagersFinance Baidu Ventures is a venture capital firm headquartered in Beijing, China. The firm was established in 2016. | Finance |
Biomap (Beijing) Intelligent Technology Co., Ltd.
Biomap (Beijing) Intelligent Technology Co., Ltd. Information Technology ServicesTechnology Services Biomap (Beijing) Intelligent Technology Co., Ltd. is a Chinese biotech company founded in 2020 by Robin Li and Wei Liu. The company is based in Beijing, China and is the first biocomputing-driven biotech company in China. Biomaps' technology, Xtrimo, is a protein-centric large language model platform that allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. The company's mission is to leverage AI and data to radically improve patients' lives by accelerating the R&D process of early screening/diagnosis, drug discovery, and other precision medicine products. Biomaps' focus is on building their internal AI engine and data collection capabilities to curate their proprietary insights for difficult diseases. The company is a startup biotech company aiming to accelerate novel drug discovery for unmet medical needs. Wei Liu has been the CEO since 2020. | Technology Services |
- Bourse
- Insiders
- Elliott Sun
- Expérience